Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...
Huge health conglomerates have another reason to worry that their business model might be disrupted. On a visit to Columbus Monday, one of the country’s top antitrust watchdogs said her agency is ...
The Federal Trade Commission (FTC) has sued the top three ... system" that it claims artificially inflated the prices of insulin products. The lawsuit – which has been anticipated since the ...
Criticism of prescription drug middlemen has intensified recently in the wake of a federal agency’s actions and legislative reform attempts. Georgia Gov. Brian Kemp, though, vetoed a related bill that ...
In late September, the Federal Trade Commission (FTC ... In its complaint, the FTC accuses these companies of inflating insulin prices and steering patients toward higher-cost insulin products ...
No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...
CVS Health is one of three pharmacy benefit managers targeted in a lawsuit from the Federal Trade Commission, which has accused the companies of driving up the price of insulin. The three firms ...
In September, the Federal Trade Commission took aim at big pharmacy benefits managers, including CVS subsidiary Caremark, accusing them of inflating insulin prices. “We are not surprised by the ...
Also: US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth’s Pharmacy Benefit Managers For Inflating Insulin Prices Last year, both companies faced challenges as they navigated ...
The Inflation Reduction Act championed by President Joe Biden and congressional Democrats included provisions limiting the cost of insulin ... also urged the Federal Trade Commission and the ...
Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...